Previous close | 7.12 |
Open | 7.18 |
Bid | 6.84 x 200 |
Ask | 6.86 x 100 |
Day's range | 6.82 - 7.20 |
52-week range | 4.74 - 9.59 |
Volume | |
Avg. volume | 1,257,638 |
Market cap | 2.722B |
Beta (5Y monthly) | 1.29 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.51 |
Earnings date | 05 Aug 2024 - 09 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 8.79 |
Comprehensive Analysis of LifeStance's First Quarter Financial Performance
LifeStance Health (LFST) delivered earnings and revenue surprises of 33.33% and 0.44%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
SCOTTSDALE, Ariz., May 09, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2024. (All results compared to prior-year comparative period, unless otherwise noted)Q1 2024 Highlights and FY 2024 Outlook Revenue of $300.4 million increased 19% compared to revenue of $252.6 millionClinician base increased 15% to 6,866 clinicians, a sequen